These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9749103)

  • 1. [Conformal radiotherapy: arguments against].
    Eschwège F
    Cancer Radiother; 1998; 2(1):81. PubMed ID: 9749103
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indications for tridimensional conformal radiotherapy in cancer of the prostate].
    Bolla M
    Cancer Radiother; 1998; 2(1):79-80. PubMed ID: 9749102
    [No Abstract]   [Full Text] [Related]  

  • 3. New wine in an old bottle? Dose escalation under dose-volume constraints: a model of conformal therapy of the prostate.
    Kutcher GJ; Leibel SA; Ling CC; Zelefsky M; Fuks Z
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):415-6. PubMed ID: 8635953
    [No Abstract]   [Full Text] [Related]  

  • 4. Three-dimensional conformal therapy (3D-CRT) for prostate cancer.
    Chuba PJ; Porter AT; Forman JD
    Cancer Treat Res; 1996; 88():147-65. PubMed ID: 9239478
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of organ and patient movements on the target volume in radiotherapy of prostatic carcinoma].
    Zimmermann FB; Molls M
    Strahlenther Onkol; 1997 Mar; 173(3):172-3. PubMed ID: 9122860
    [No Abstract]   [Full Text] [Related]  

  • 6. The challenge for conformal therapy for prostate cancer.
    Beard CJ; Kaplan ID; Coleman CN
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):705-7. PubMed ID: 8331005
    [No Abstract]   [Full Text] [Related]  

  • 7. Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose escalation study.
    Phillips TL
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):325-6; discussion 327-8. PubMed ID: 8270457
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of treatment techniques for conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities.
    Roach M
    Radiother Oncol; 1996 Jul; 40(1):85-7. PubMed ID: 8844893
    [No Abstract]   [Full Text] [Related]  

  • 9. [Radiation therapy for prostate cancer].
    Sumi M
    Nihon Rinsho; 2005 Feb; 63(2):279-85. PubMed ID: 15714979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Three-dimensional radiation therapy. Report of the "2nd International Symposium 3-D Radiation Treatment Planning and Conformal Therapy". 11-13 April 1996, Saint-Louis, Missouri, USA].
    Touboul E; Foulquier JN
    Bull Cancer Radiother; 1996; 83(3):187-95. PubMed ID: 8977574
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose rate in external beam radiotherapy for prostate cancer: an overlooked confounding variable?
    Welsh JS; Howard SP; Fowler JF
    Urology; 2003 Aug; 62(2):204-6. PubMed ID: 12893319
    [No Abstract]   [Full Text] [Related]  

  • 12. 3-D conformal radiotherapy for prostate cancer. The University of Michigan experience.
    Sandler HM
    Front Radiat Ther Oncol; 1996; 29():238-43. PubMed ID: 8742904
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prostate cancer].
    Vieillot S; Fenoglietto P; Aillères N; Hay MH; Dubois JB; Azria D
    Cancer Radiother; 2010 Nov; 14 Suppl 1():S161-73. PubMed ID: 21129660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the evidence support the enthusiasm over 3D conformal radiation therapy and dose escalation in the treatment of prostate cancer?
    Purdy JA; Michalski JM
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):867-70. PubMed ID: 11704308
    [No Abstract]   [Full Text] [Related]  

  • 15. Multi-institutional clinical trials: 3-D conformal radiotherapy quality assurance. Guidelines in an NCI/RTOG study evaluating dose escalation in prostate cancer radiotherapy.
    Purdy JA; Harms WB; Michalski J; Cox JD
    Front Radiat Ther Oncol; 1996; 29():255-63. PubMed ID: 8742907
    [No Abstract]   [Full Text] [Related]  

  • 16. Comment on "Quantifying the interplay effect in prostate IMRT delivery using a convolution-based method" [Med. Phys. 35, 1703-1710 (2008)].
    King RP; Anderson RS; Kandagatla KK
    Med Phys; 2008 Dec; 35(12):5955-6. PubMed ID: 19175150
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment on "A planning quality evaluation tool for prostate adaptive IMRT based on machine learning" [Med. Phys. 38, 719 (2011)].
    Kazhdan M; McNutt T; Taylor R; Wu B; Simari P
    Med Phys; 2011 May; 38(5):2820; author reply 2821. PubMed ID: 21776819
    [No Abstract]   [Full Text] [Related]  

  • 18. [III. The Advantages and Disadvantages of IMRT and Particle Therapy for Prostate Cancer].
    Nakamura K; Konishi K; Komatsu T; Shioyama Y; Matsumoto K
    Gan To Kagaku Ryoho; 2017 Jan; 44(1):37-40. PubMed ID: 28676618
    [No Abstract]   [Full Text] [Related]  

  • 19. Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001).
    Ost P; Fonteyne V; De Neve W; De Gersem W; De Wagter C; Vandecasteele K; Duprez F; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1286; author reply 1287. PubMed ID: 19251105
    [No Abstract]   [Full Text] [Related]  

  • 20. External beam radiotherapy of localized prostatic adenocarcinoma. Evaluation of conformal therapy, field number and target margins.
    Lennernäs B; Rikner G; Letocha H; Nilsson S
    Acta Oncol; 1995; 34(7):953-8. PubMed ID: 7492387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.